FGF2 is a molecule significantly more stable than FGF1, and binds to FGFR1, FGFR3 and, to a lesser extent, to FGFR2, allowing it to be a targeting molecule for a large group of FGFR-overexpressing cancers [29]. Here, FGF2 is linked to cancer.